HealthCare Global Enterprises Ltd, The Specialist in Cancer Care, is the first hospital in Asia to introduce the Varian TrueBeam Technology and Siemens PreScision Artiste in cancer treatment.
Dr. B S Ajaikumar, Chairman, HCG, said, “HCG has played a vital role in redefining cancer treatment in India, through expertise and technology. As a leader in oncology it is our endeavor to ensure the most advanced radiation therapy technology in cancer treatment is available in India. For the first time in Asia, we have introduced TrueBeam Technology in Ahmedabad and PreScision Artiste at Bangalore. Both these technologies will help in the faster and effective treatment for patients.”
Dr. Kumar Swamy, Consultant, Radiation Oncologist, HCG, said, “PreScision Artiste and TrueBeam can be used for all cancer types requiring radiotherapy. It is specifically unique in delivering radio therapy for its precision. Integrated imaging allows Respiratory gated treatments which involves tumor tracking of mobile tumors which move with respiration (e.g. lung cancer) thereby reducing acute toxicity and brings out maximal therapeutic gain. It offers more convenience for the patient by shortening treatment time.”
About HCG:
Health Care Global Enterprises Ltd, (HCG), The Specialist in Cancer Care, headquartered in Bangalore with over 23 cancer centers is South Asia’s largest cancer care network. HCG has defined the future of cancer care in India by designing, building and managing cancer care centres with a committed vision. HCG focuses on cancer care treatment, imaging and laboratory services, clinical trials and research services. The vision of HCG is to make high quality cancer care accessible by adopting global innovations to all segments of the society.
TrueBeam and PreScision Artiste:
TrueBeam and PreScision Artiste is a new radiotherapy treatment in cancer treatment. The radiotherapy system uses a completely re-engineered control system with a multitude of technical innovations to dynamically synchronize imaging, patient positioning, motion management, and treatment delivery. Radiotherapy can be used for treatment of all cancer types requiring radiotherapy. The total treatment time can be drastically cut down with new technology and this increases the patient’s compliance to treatment. Due to integration and speed of imaging methods in the process of the treatment delivery with high precision – side effects are reduced with an increase in protection of normal tissue and treatment efficiency on the tumor is increased by modulating intensity. The patients will not feel anything during the treatment and it is safe. These technologies can be performed for all types of age, stage and types of tumor and provides important advantage for patients who are not considered as appropriate for surgery because of advanced age.
Advantages of TrueBeam and PreScision Artiste:
# It is more precise and performs irradiation hitting treatment focus better.
# It provides a higher performance treatment process and reduces the number of sessions
# It is a technology offering radiotherapy and radiosurgery options integrated on the same platform in a more convenient way for the patient.
# Due to reduced toxicity chemotherapy can be safely given with radiation without breaks thereby enhancing radiation effect where organ preservation is of prime importance
# New generation fully digital Linac with Rapidarc treatments allow treatment to be faster thereby adding to patient’s comfort.
About HCG:
HealthCare Global Enterprises Ltd. (HCG), a leader in oncology care in India, currently manages a network of 20 cancer centres across Asia. HCG focuses on cancer treatment centres, imaging & laboratory services and clinical trials & research services. The vision of HCG is to provide high quality, integrated, comprehensive cancer treatment to all segments of society. Bangalore Institute of Oncology (BIO), the flagship of HCG, set up almost 2 decades back was the first dedicated comprehensive cancer centre to be established in the private sector in India. Under the guidance of Dr. B.S. Ajaikumar, BIO acquired Curie Centre of Oncology in 2000 and re-christened it as HealthCare Global Enterprises Ltd. Besides expanding to other geographies nationally, HCG acquired Triesta Sciences in December 2005. Under this banner HCG runs a high end Onco-Reference Laboratory, Biomarker research & validation R&D laboratory and Contracted Research Organization - CRO.
Sourced From: HealthCare Global Enterprises Ltd
Dr. B S Ajaikumar, Chairman, HCG, said, “HCG has played a vital role in redefining cancer treatment in India, through expertise and technology. As a leader in oncology it is our endeavor to ensure the most advanced radiation therapy technology in cancer treatment is available in India. For the first time in Asia, we have introduced TrueBeam Technology in Ahmedabad and PreScision Artiste at Bangalore. Both these technologies will help in the faster and effective treatment for patients.”
Dr. Kumar Swamy, Consultant, Radiation Oncologist, HCG, said, “PreScision Artiste and TrueBeam can be used for all cancer types requiring radiotherapy. It is specifically unique in delivering radio therapy for its precision. Integrated imaging allows Respiratory gated treatments which involves tumor tracking of mobile tumors which move with respiration (e.g. lung cancer) thereby reducing acute toxicity and brings out maximal therapeutic gain. It offers more convenience for the patient by shortening treatment time.”
About HCG:
Health Care Global Enterprises Ltd, (HCG), The Specialist in Cancer Care, headquartered in Bangalore with over 23 cancer centers is South Asia’s largest cancer care network. HCG has defined the future of cancer care in India by designing, building and managing cancer care centres with a committed vision. HCG focuses on cancer care treatment, imaging and laboratory services, clinical trials and research services. The vision of HCG is to make high quality cancer care accessible by adopting global innovations to all segments of the society.
TrueBeam and PreScision Artiste:
TrueBeam and PreScision Artiste is a new radiotherapy treatment in cancer treatment. The radiotherapy system uses a completely re-engineered control system with a multitude of technical innovations to dynamically synchronize imaging, patient positioning, motion management, and treatment delivery. Radiotherapy can be used for treatment of all cancer types requiring radiotherapy. The total treatment time can be drastically cut down with new technology and this increases the patient’s compliance to treatment. Due to integration and speed of imaging methods in the process of the treatment delivery with high precision – side effects are reduced with an increase in protection of normal tissue and treatment efficiency on the tumor is increased by modulating intensity. The patients will not feel anything during the treatment and it is safe. These technologies can be performed for all types of age, stage and types of tumor and provides important advantage for patients who are not considered as appropriate for surgery because of advanced age.
Advantages of TrueBeam and PreScision Artiste:
# It is more precise and performs irradiation hitting treatment focus better.
# It provides a higher performance treatment process and reduces the number of sessions
# It is a technology offering radiotherapy and radiosurgery options integrated on the same platform in a more convenient way for the patient.
# Due to reduced toxicity chemotherapy can be safely given with radiation without breaks thereby enhancing radiation effect where organ preservation is of prime importance
# New generation fully digital Linac with Rapidarc treatments allow treatment to be faster thereby adding to patient’s comfort.
About HCG:
HealthCare Global Enterprises Ltd. (HCG), a leader in oncology care in India, currently manages a network of 20 cancer centres across Asia. HCG focuses on cancer treatment centres, imaging & laboratory services and clinical trials & research services. The vision of HCG is to provide high quality, integrated, comprehensive cancer treatment to all segments of society. Bangalore Institute of Oncology (BIO), the flagship of HCG, set up almost 2 decades back was the first dedicated comprehensive cancer centre to be established in the private sector in India. Under the guidance of Dr. B.S. Ajaikumar, BIO acquired Curie Centre of Oncology in 2000 and re-christened it as HealthCare Global Enterprises Ltd. Besides expanding to other geographies nationally, HCG acquired Triesta Sciences in December 2005. Under this banner HCG runs a high end Onco-Reference Laboratory, Biomarker research & validation R&D laboratory and Contracted Research Organization - CRO.
Sourced From: HealthCare Global Enterprises Ltd
